Tags

Type your tag names separated by a space and hit enter

Changes in depressive symptoms and glycemic control in diabetes mellitus.
Psychosom Med. 2007 Apr; 69(3):235-41.PM

Abstract

OBJECTIVE

To investigate if changes in depressive symptoms would be associated with changes in glycemic control over a 12-month period in patients with Type 1 and Type 2 diabetes.

METHODS

Ninety (Type 1 diabetes, n = 28; Type 2 diabetes, n = 62) patients having Beck Depression Inventory (BDI) levels of >10 were enrolled in the study. Of those 90 patients, 65 patients completed a 12-week cognitive behavioral therapy intervention. BDI was assessed at baseline and thereafter biweekly during 12 months. Hemoglobin (HbA1c) and fasting blood glucose levels were assessed at baseline and at four quarterly in-hospital follow-up visits. Linear mixed-model analysis was applied to determine the effects of time and diabetes type on depressive symptoms, HbA1c levels, and fasting glucose levels.

RESULTS

Mean and standard deviation baseline BDI and HbA1c levels were 17.9 +/- 5.8 and 7.6 +/- 1.6, respectively, with no significant difference between patients with Type 1 and Type 2 diabetes. Mixed-model regression analysis found no difference between the groups with Type 1 and Type 2 diabetes in the within-subject effect of BDI score on HbA1c or fasting glucose levels during the study. Depressive symptoms decreased significantly (p = .0001) and similarly over a 12-month period in both patients with Type 1 and Type 2 diabetes, whereas HbA1c and fasting glucose levels did not change significantly over time in either group.

CONCLUSION

Changes in depressive symptoms were not associated with changes in HbA1c or fasting glucose levels over a 1-year period in either patients with Type 1 or Type 2 diabetes.

Authors+Show Affiliations

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Box 3842, Durham, NC 27710, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

17420441

Citation

Georgiades, Anastasia, et al. "Changes in Depressive Symptoms and Glycemic Control in Diabetes Mellitus." Psychosomatic Medicine, vol. 69, no. 3, 2007, pp. 235-41.
Georgiades A, Zucker N, Friedman KE, et al. Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med. 2007;69(3):235-41.
Georgiades, A., Zucker, N., Friedman, K. E., Mosunic, C. J., Applegate, K., Lane, J. D., Feinglos, M. N., & Surwit, R. S. (2007). Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosomatic Medicine, 69(3), 235-41.
Georgiades A, et al. Changes in Depressive Symptoms and Glycemic Control in Diabetes Mellitus. Psychosom Med. 2007;69(3):235-41. PubMed PMID: 17420441.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Changes in depressive symptoms and glycemic control in diabetes mellitus. AU - Georgiades,Anastasia, AU - Zucker,Nancy, AU - Friedman,Kelli E, AU - Mosunic,Christopher J, AU - Applegate,Katherine, AU - Lane,James D, AU - Feinglos,Mark N, AU - Surwit,Richard S, Y1 - 2007/04/09/ PY - 2007/4/11/pubmed PY - 2007/6/8/medline PY - 2007/4/11/entrez SP - 235 EP - 41 JF - Psychosomatic medicine JO - Psychosom Med VL - 69 IS - 3 N2 - OBJECTIVE: To investigate if changes in depressive symptoms would be associated with changes in glycemic control over a 12-month period in patients with Type 1 and Type 2 diabetes. METHODS: Ninety (Type 1 diabetes, n = 28; Type 2 diabetes, n = 62) patients having Beck Depression Inventory (BDI) levels of >10 were enrolled in the study. Of those 90 patients, 65 patients completed a 12-week cognitive behavioral therapy intervention. BDI was assessed at baseline and thereafter biweekly during 12 months. Hemoglobin (HbA1c) and fasting blood glucose levels were assessed at baseline and at four quarterly in-hospital follow-up visits. Linear mixed-model analysis was applied to determine the effects of time and diabetes type on depressive symptoms, HbA1c levels, and fasting glucose levels. RESULTS: Mean and standard deviation baseline BDI and HbA1c levels were 17.9 +/- 5.8 and 7.6 +/- 1.6, respectively, with no significant difference between patients with Type 1 and Type 2 diabetes. Mixed-model regression analysis found no difference between the groups with Type 1 and Type 2 diabetes in the within-subject effect of BDI score on HbA1c or fasting glucose levels during the study. Depressive symptoms decreased significantly (p = .0001) and similarly over a 12-month period in both patients with Type 1 and Type 2 diabetes, whereas HbA1c and fasting glucose levels did not change significantly over time in either group. CONCLUSION: Changes in depressive symptoms were not associated with changes in HbA1c or fasting glucose levels over a 1-year period in either patients with Type 1 or Type 2 diabetes. SN - 1534-7796 UR - https://www.unboundmedicine.com/medline/citation/17420441/Changes_in_depressive_symptoms_and_glycemic_control_in_diabetes_mellitus_ L2 - https://doi.org/10.1097/PSY.0b013e318042588d DB - PRIME DP - Unbound Medicine ER -